<DOC>
	<DOCNO>NCT01440764</DOCNO>
	<brief_summary>The purpose protocol develop test optimal delivery aerosol furosemide , treatment potential significantly improve symptom management enhance quality care patient intractable dyspnea .</brief_summary>
	<brief_title>Aerosol Inhalation Treatment Dyspnea</brief_title>
	<detailed_description>This study aerosol treatment laboratory model dyspnea healthy subject . This study first series study include investigation second dose laboratory investigation treatment effect hospitalize patient refractory dyspnea . The outcome first study determine detail protocol succeed study .</detailed_description>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Healthy Unstable heart circulation disease Stroke Seizure disorder Severe migraine headache Liver kidney disease Adrenal gland problem ( Pheochromocytoma ) Nerve problem may affect breathe sensation Brain cancer Drug alcohol problem Systemic lupus erythematosis ( SLE ) High level depression , panic disorder , significant mental health problem Serious ongoing pain Pregnant Under 18 year old Not Fluent English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>dyspnea</keyword>
	<keyword>Laboratory model dyspnea healthy subject</keyword>
</DOC>